| Name | Ethyl 4-hydroxy-2-(trifluoromethyl)quinoline-3-carboxylate |
|---|---|
| Synonyms |
2-Cyano-5-hydroxybenzotrifluoride
Ethyl 2-trifluoromethyl-4-hydroxy-3-quinolinecarboxylate 4-hydroxy-2-trifluoromethyl-quinoline-3-carboxylic acid ethyl ester 4-Hydroxy-2-trifluormethyl-benzonitril 4-hydroxy-2-trifluoromethylbenzonitrile 4-Cyano-3-(trifluoromethyl)phenol |
| Density | 1.404g/cm3 |
|---|---|
| Boiling Point | 348.8ºC at 760 mmHg |
| Molecular Formula | C13H10F3NO3 |
| Molecular Weight | 285.21900 |
| Flash Point | 164.7ºC |
| Exact Mass | 285.06100 |
| PSA | 59.42000 |
| LogP | 3.13590 |
| Index of Refraction | 1.557 |
| HS Code | 2933499090 |
|---|
|
~%
75999-59-6 |
| Literature: Vertex Pharmaceuticals Incorporated Patent: US2012/309758 A1, 2012 ; Location in patent: Page/Page column 63 ; US 20120309758 A1 |
|
~%
75999-59-6 |
| Literature: Roussel Uclaf Patent: US4299831 A1, 1981 ; |
|
~%
75999-59-6 |
| Literature: Vertex Pharmaceuticals Incorporated Patent: US2012/309758 A1, 2012 ; US 20120309758 A1 |
|
~%
75999-59-6 |
| Literature: Vertex Pharmaceuticals Incorporated Patent: US2012/309758 A1, 2012 ; US 20120309758 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |